|
1
|
Kanai F, Marignani PA, Sarbassova D, Yagi
R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC
and Yaffe MB: TAZ: A novel transcriptional co-activator regulated
by interactions with 14-3-3 and PDZ domain proteins. EMBO J.
19:6778–6791. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Varelas X, Sakuma R, Samavarchi-Tehrani P,
Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW and Wrana JL:
TAZ controls Smad nucleocytoplasmic shuttling and regulates human
embryonic stem-cell self-renewal. Nat Cell Biol. 10:837–848. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dong J, Feldmann G, Huang J, Wu S, Zhang
N, Comerford SA, Gayyed MF, Anders RA, Maitra A and Pan D:
Elucidation of a universal size-control mechanism in
Drosophila and mammals. Cell. 130:1120–1133. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lei QY, Zhang H, Zhao B, Zha ZY, Bai F,
Pei XH, Zhao S, Xiong Y and Guan KL: TAZ promotes cell
proliferation and epithelial-mesenchymal transition and is
inhibited by the hippo pathway. Mol Cell Biol. 28:2426–2436. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chow A, Hao Y and Yang X: Molecular
characterization of human homologs of yeast MOB1. Int J Cancer.
126:2079–2089. 2010.PubMed/NCBI
|
|
6
|
Piccolo S, Dupont S and Cordenonsi M: The
biology of YAP/TAZ: Hippo signaling and beyond. Physiol Rev.
94:1287–1312. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang L, Shi S, Guo Z, Zhang X, Han S, Yang
A, Wen W and Zhu Q: Overexpression of YAP and TAZ is an independent
predictor of prognosis in colorectal cancer and related to the
proliferation and metastasis of colon cancer cells. PLoS One.
8:e655392013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kang W, Tong JH, Chan AW, Lee TL, Lung RW,
Leung PP, So KK, Wu K, Fan D, Yu J, et al: Yes-associated protein 1
exhibits oncogenic property in gastric cancer and its nuclear
accumulation associates with poor prognosis. Clin Cancer Res.
17:2130–2139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zender L, Spector MS, Xue W, Flemming P,
Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, et
al: Identification and validation of oncogenes in liver cancer
using an integrative oncogenomic approach. Cell. 125:1253–1267.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Muramatsu T, Imoto I, Matsui T, Kozaki K,
Haruki S, Sudol M, Shimada Y, Tsuda H, Kawano T and Inazawa J: YAP
is a candidate oncogene for esophageal squamous cell carcinoma.
Carcinogenesis. 32:389–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Dong Q, Zhang Q, Li Z, Wang E and
Qiu X: Overexpression of yes-associated protein contributes to
progression and poor prognosis of non-small-cell lung cancer.
Cancer Sci. 101:1279–1285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Su L and Ou Q: Yes-associated
protein promotes tumour development in luminal epithelial derived
breast cancer. Eur J Cancer. 48:1227–1234. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan SW, Lim CJ, Guo K, Ng CP, Lee I,
Hunziker W, Zeng Q and Hong W: A role for TAZ in migration,
invasion, and tumorigenesis of breast cancer cells. Cancer Res.
68:2592–2598. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS
and Yang X: TAZ is a novel oncogene in non-small cell lung cancer.
Oncogene. 30:2181–2186. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Horn LC, Meinel A, Handzel R and Einenkel
J: Histopathology of endometrial hyperplasia and endometrial
carcinoma: An update. Ann Diagn Pathol. 11:297–311. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mamat S, Ikeda J, Enomoto T, Ueda Y,
Rahadiani N, Tian T, Wang Y, Qiu Y, Kimura T, Aozasa K and Morii E:
Prognostic significance of CUB domain containing protein expression
in endometrioid adenocarcinoma. Oncol Rep. 23:1221–1227.
2010.PubMed/NCBI
|
|
18
|
Rahadiani N, Ikeda J, Mamat S, Matsuzaki
S, Ueda Y, Umehara R, Tian T, Wang Y, Enomoto T, Kimura T, et al:
Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid
adenocarcinoma and its clinical implications. Cancer Sci.
102:903–908. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Ikeda JI, Rahadiani N, Mamat S,
Ueda Y, Tian T, Enomoto T, Kimura T, Aozasa K and Morii E:
Prognostic significance of elongator protein 3 expression in
endometrioid adenocarcinoma. Oncol Lett. 3:25–29. 2012.PubMed/NCBI
|
|
20
|
Tsujiura M, Mazack V, Sudol M, Kaspar HG,
Nash J, Carey DJ and Gogoi R: Yes-associated protein (YAP)
modulates oncogenic features and radiation sensitivity in
endometrial cancer. PLoS One. 9:e1009742014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zaino RJ: FIGO staging of endometrial
adenocarcinoma: A critical review and proposal. Int J Gynecol
Pathol. 28:1–9. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim
J, Xie J, Ikenoue T, Yu J, Li L, et al: Inactivation of YAP
oncoprotein by the Hippo pathway is involved in cell contact
inhibition and tissue growth control. Genes Dev. 21:2747–2761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goulev Y, Fauny JD, Gonzalez-Marti B,
Flagiello D, Silber J and Zider A: SCALLOPED interacts with YORKIE,
the nuclear effector of the hippo tumor-suppressor pathway in
Drosophila. Curr Biol. 18:435–441. 2008. View Article : Google Scholar : PubMed/NCBI
|
